Mangoceuticals, Inc. (MGRX)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Personal Products	615.87K	731.49K	8.94K
Personal Products Growth	-15.81%	8083.16%	-
Total	615.87K	731.49K	8.94K
Total Growth	-15.81%	8083.16%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	615.87K	731.49K	8.94K
United States Growth	-15.81%	8083.16%	-
Total	615.87K	731.49K	8.94K
Total Growth	-15.81%	8083.16%	-

Source: S&P Global Market Intelligence.